Overview
Darren Abrahams and Hannah Widemann have authored an article title “Expert Focus: What Do Changes to the Data Requirements of Annex II and III of the BPR Mean for Applicants?” for Chemical Watch. The June article highlights how the Commission Delegated Regulation (EU) 2021/525 aims to clarify data requirements to determine the endocrine-disrupting properties of active substances and biocidal products. Abrahams and Widemann discuss the main aspects of the regulation and its likely impacts on the industry. Read the full analysis at Chemical Watch (subscription required).
